Edwards Lifesciences Corp (EW) · Insider Trading (Form 4) SEC Filing

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-05-15 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Edwards Lifesciences Corp (EW) CIK: 0001099800 --- Reporting Owner --- Name: BOBO DONALD E JR CIK: 0001196661 Role: Officer (CVP,Strategy/Corp Development) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-05-15 | Code: S (Open market sale) Shares: -9,968 | Price: $82.07 Total Value: $818,105.66 Shares Owned After: 22,798.2532 | Ownership: D (Direct) Footnotes: [F1] This transaction was executed in multiple trades at prices ranging from $81.975 to $82.260. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. [Transaction #2] Security: Common Stock Date: 2026-05-15 | Code: S (Open market sale) Shares: -8,000 | Price: $81.82 Total Value: $654,572.80 Shares Owned After: 30,969.5756 | Ownership: I (Indirect) | Nature: 401(k) --- Holdings --- [Holding #1] Security: Common Stock Ownership: I (Indirect) --- Footnotes (Complete Index) --- F1: This transaction was executed in multiple trades at prices ranging from $81.975 to $82.260. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. --- Signature --- /s/ Linda J. Park, Attorney-in-Fact (2026-05-18)